Research Interests 【 display / non-display 】

Research Interests 【 display / non-display 】

Graduating School 【 display / non-display 】

Graduating School 【 display / non-display 】

• 2007.04

  -

  2011.03

  Akita University   Faculty of Medicine   Graduated

• 2001.04

  -

  2005.03

  Tokyo Institute of Technology   Faculty of Science   Graduated

Graduate School 【 display / non-display 】

Graduate School 【 display / non-display 】

• 2014.04

  -

  2019.03

  Akita University  Graduate School, Division of Medicine  Doctor's Course  Completed

• 2005.04

  -

  2007.03

  The University of Tokyo    Master's Course  Completed

Campus Career 【 display / non-display 】

Campus Career 【 display / non-display 】

• 2022.04

  -

  Now

  Akita University   Hospital   Clinical Oncology   Specially-appointed Assistant Professor  

• 2019.04

  -

  2022.03

  Akita University   School of Medicine   Endowed Departments   Assistant Professor appointed to endowed chairs  

Thesis for a degree 【 display / non-display 】

Thesis for a degree 【 display / non-display 】

• Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.

  Shimazu K, Inoue M, Sugiyama S, Fukuda K, Yoshida T, Taguchi D, Uehara Y, Kuriyama S, Tanaka M, Miura M, Nanjyo H, Iwabuchi Y, Shibata H 

  Cancer science  109 ( 10 ) 3285 - 3293   2019.03

  Single author

  DOI

Research Achievements 【 display / non-display 】

Research Achievements 【 display / non-display 】

◆Original paper【 display / non-display 】

To the head of this page.▲

◆Original paper【 display / non-display 】

Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.

Taguchi D, Inoue M, Fukuda K, Yoshida T, Shimazu K, Fujita K, Okuyama H, Matsuhashi N, Tsuji A, Yoshida K, Miura M, Shibata H

International Journal of Clinical Oncology     2019.12  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.

Shimazu K, Inoue M, Sugiyama S, Fukuda K, Yoshida T, Taguchi D, Uehara Y, Kuriyama S, Tanaka M, Miura M, Nanjyo H, Iwabuchi Y, Shibata H

Cancer science   109 ( 10 ) 3285 - 3293   2018.08  [Refereed]

Research paper (journal)   Domestic Co-author

Guillain-Barré syndrome in a cancer patient treated with bevacizumab.

Taguchi D, Kamada S, Yoshida T, Fukuda K, Shimazu K, Inoue M, Sugawara M, Nanjyo H, Iijima K, Shibata H

International Cancer Conference Journal     2018.05  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Effect of anti-PD-1 antibody, nivolumab on early gastric cancer.

Fukuda K, Yoshida T, Shimazu K, Taguchi D, Inoue M, Nanjyo H, Shibata H.

International Cancer Conference Journal     2017.03

Research paper (journal)   Domestic Co-author

DOI